🔗 Share this article Users Discontinuing Weight-Loss Injections Regain Pounds Four Times Faster Compared to People Using Diet and Exercise Weight management involves long-term strategies. New research suggests that individuals who discontinue popular slimming jabs like Mounjaro or Wegovy may regain shed pounds much more quickly than those who end traditional lifestyle plans. Published data in a prominent health publication demonstrates that while overweight people frequently drop a large proportion of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month after stopping. "Individuals purchasing these drugs need to be aware of the danger of fast weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb. This pace of regain suggests a return to starting mass in about a year and a half. Comparing Therapies The study, which looked at dozens of studies involving over 9,000 of participants, compared the results of these new drugs with other pills. The team note that individuals who lose weight through dieting generally see a more gradual creep back—perhaps 0.1 kg a month—after stopping. Explaining the Quick Rebound Experts believe the way of the drugs accounts for the amplified rebound. The injections mimic a natural hormone called glucagon-like peptide-1, which moderates appetite. "Artificially providing GLP-1 levels several times higher than normal might result in the system to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist. "Discontinuation of this hormone supplement leads to hunger is unsuppressed, making binge eating far more likely." An Ongoing Issue? The NHS recommend the injections for individuals with obesity-related medical conditions, alongside recommended lifestyle changes. Professionals argue that, given the likelihood of relapse, the therapy should be considered ongoing. This view is reinforced by drug manufacturers, who note that the findings "highlight the long-term character of obesity," akin to managing conditions like diabetes. Patient Testimonies Individuals who have come off the jabs report a sudden return of appetite. "It felt as if a switch activating and I was suddenly starving," recalled an individual. This challenge is compounded if users have not established permanent dietary or behavioural changes during treatment. Widespread Adoption Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial. Use is more common among women compared to men. The 40s and 50s age group shows the greatest level of interest. Many obtain the medications through private healthcare rather than public health services. In conclusion, experts emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent fix and maintained weight loss relies on ongoing lifestyle management.
Weight management involves long-term strategies. New research suggests that individuals who discontinue popular slimming jabs like Mounjaro or Wegovy may regain shed pounds much more quickly than those who end traditional lifestyle plans. Published data in a prominent health publication demonstrates that while overweight people frequently drop a large proportion of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month after stopping. "Individuals purchasing these drugs need to be aware of the danger of fast weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb. This pace of regain suggests a return to starting mass in about a year and a half. Comparing Therapies The study, which looked at dozens of studies involving over 9,000 of participants, compared the results of these new drugs with other pills. The team note that individuals who lose weight through dieting generally see a more gradual creep back—perhaps 0.1 kg a month—after stopping. Explaining the Quick Rebound Experts believe the way of the drugs accounts for the amplified rebound. The injections mimic a natural hormone called glucagon-like peptide-1, which moderates appetite. "Artificially providing GLP-1 levels several times higher than normal might result in the system to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist. "Discontinuation of this hormone supplement leads to hunger is unsuppressed, making binge eating far more likely." An Ongoing Issue? The NHS recommend the injections for individuals with obesity-related medical conditions, alongside recommended lifestyle changes. Professionals argue that, given the likelihood of relapse, the therapy should be considered ongoing. This view is reinforced by drug manufacturers, who note that the findings "highlight the long-term character of obesity," akin to managing conditions like diabetes. Patient Testimonies Individuals who have come off the jabs report a sudden return of appetite. "It felt as if a switch activating and I was suddenly starving," recalled an individual. This challenge is compounded if users have not established permanent dietary or behavioural changes during treatment. Widespread Adoption Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial. Use is more common among women compared to men. The 40s and 50s age group shows the greatest level of interest. Many obtain the medications through private healthcare rather than public health services. In conclusion, experts emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent fix and maintained weight loss relies on ongoing lifestyle management.